Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591382 · ClinicalTrials.gov registry record · Phase 4
Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT01591382 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 64 participants.
The verdict
NCT01591382, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
Patients who are dependent on opioids often have poor pain relief after major surgery. This study tests the hypothesis that adding intravenous ketamine to a postoperative regimen of intravenous opioids for postoperative pain will improve pain relief in this subset of patients.
Interventions
- DRUG Placebo
- DRUG Ketamine
- DRUG Hydromorphone PCA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01591382
The ClinicalTrials.gov registry entry for NCT01591382 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01591382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01591382 about?
NCT01591382 is a clinical study titled "Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients". Patients who are dependent on opioids often have poor pain relief after major surgery. This study tests the hypothesis that adding intravenous ketamine to a postoperative regimen of intravenous opioids for postoperative pain will improve pain relief in this subset of patients.
What is the current status of trial NCT01591382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2008-09. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01591382?
The interventions under investigation include: Placebo (DRUG), Ketamine (DRUG), Hydromorphone PCA (DRUG).
Who is sponsoring clinical trial NCT01591382?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.